Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer; EJNMMI Research; Vol. 10, iss. 1
| Parent link: | EJNMMI Research Vol. 10, iss. 1.— 2020.— [21, 10 p.] |
|---|---|
| Corporate Author: | Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий |
| Other Authors: | Alhuseinalkhudhur A. Ali, Lubberink M. Mark, Lindman H. Henrik, Tolmachev V. M. Vladimir Maksimilianovich, Frejd F. Y. Fredrik, Feldwisch J. Joachim, Velikyan I. Irina, Sorensen J. Jens |
| Summary: | Title screen High expression of human epidermal growth factor receptor type 2 (HER2) represents an aggressive subtype of breast cancer. Anti-HER2 treatment requires a theragnostic approach wherein sufficiently high receptor expression in biopsy material is mandatory. Heterogeneity and discordance of HER2 expression between primary tumour and metastases, as well as within a lesion, present a complication for the treatment and require multiple biopsies. Molecular imaging using the HER2-targeting Affibody peptide ABY-025 radiolabelled with 68Ga-gallium for PET/CT is currently under investigation as a non-invasive tool for whole-body evaluation of metastatic HER2 expression. Initial studies demonstrated a high correlation between 68Ga-ABY-025 standardized uptake values (SUVs) and histopathology. However, detecting small liver lesions might be compromised by high background uptake. This study aimed to explore the applicability of kinetic modelling and parametric image analysis for absolute quantification of 68Ga-ABY-025 uptake and HER2-receptor expression and how that relates to static SUVs. Режим доступа: по договору с организацией-держателем ресурса |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13550-020-0603-9 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=662556 |
Similar Items
Affibody Molecules as Targeting Vectors for PET Imaging; Cancers; Vol. 12, iss. 3
by: Tolmachev V. M. Vladimir Maksimilianovich
Published: (2020)
by: Tolmachev V. M. Vladimir Maksimilianovich
Published: (2020)
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model; Cancers; Vol. 13, iss. 1
Published: (2020)
Published: (2020)
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - iss. 9
Published: (2023)
Published: (2023)
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer; Theranostics; Vol. 13, iss. 14
Published: (2023)
Published: (2023)
Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules; International Journal of Molecular Sciences; Vol. 21, iss. 6
Published: (2020)
Published: (2020)
Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation; Journal of Controlled Release; Vol. 370
Published: (2024)
Published: (2024)
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs; Journal of Controlled Release; Vol. 355
Published: (2023)
Published: (2023)
Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules; International Journal of Molecular Sciences; Vol. 21, iss. 4
Published: (2020)
Published: (2020)
Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model; Pharmaceutics; Vol. 12, iss. 6
Published: (2020)
Published: (2020)
HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution; Pharmaceutics; Vol. 12, iss. 4
Published: (2020)
Published: (2020)
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8; Pharmaceutics; Vol. 17, iss. 8
Published: (2025)
Published: (2025)
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake; International Journal of Molecular Sciences; Vol. 22, iss. 5
Published: (2021)
Published: (2021)
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer; Molecules; Vol. 25, iss. 24
Published: (2020)
Published: (2020)
The problem of breast cancer diagnosis; Journal of Economics and Social Sciences; № 16
by: Tretyakova M. S. Maria Sergeevna
Published: (2020)
by: Tretyakova M. S. Maria Sergeevna
Published: (2020)
New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families; Cancer Biomarkers; Vol. 18, iss. 5
Published: (2017)
Published: (2017)
Use of multi-angle ultra-wide band microwave sounding for high resolution breast imaging; Medical Physics; Vol. 47, iss.10
Published: (2020)
Published: (2020)
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1; Molecules; Vol. 25, iss. 20
Published: (2020)
Published: (2020)
A multi-level thresholding method for breast thermograms analysis using Dragonfly algorithm; Infrared Physics & Technology; Vol. 93
Published: (2019)
Published: (2019)
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer; Pharmaceutics; Vol. 12, iss. 10
Published: (2020)
Published: (2020)
Ресайклинг синтетических волокон и тканей химическим методом; Перспективы развития фундаментальных наук; Т. 2 : Химия
by: Манапова Е. Э.
Published: (2025)
by: Манапова Е. Э.
Published: (2025)
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer; Cancers; Vol. 15 - iss. 12
Published: (2023)
Published: (2023)
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3; Nuclear Medicine and Biology; Vol. 124-125
Published: (2023)
Published: (2023)
Выявление скрытых закономерностей в социально-психологических исследованиях; Известия Томского политехнического университета [Известия ТПУ]; Т. 306, № 5
by: Муратова Е. А. Елена Анатольевна
Published: (2003)
by: Муратова Е. А. Елена Анатольевна
Published: (2003)
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion; International Journal of Molecular Sciences; Vol. 25, iss. 8
Published: (2024)
Published: (2024)
Efficient Synthesis of ω‐[18F]Fluoroaliphatic Carboxylic Esters and Acids for Positron Emission Tomography; European Journal of Organic Chemistry; Vol. 2020, iss. 40
Published: (2020)
Published: (2020)
Генетически модифицированная клеточная линия с гиперэкспрессией гена MYC; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
by: Долгашева Д. С.
Published: (2024)
by: Долгашева Д. С.
Published: (2024)
Radiolabeling Strategies of Micron- and Submicron-Sized Core–Shell Carriers for In Vivo Studies; ACS Applied Materials and Interfaces; Vol. 12, iss. 28
Published: (2020)
Published: (2020)
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Published: (2025)
Published: (2025)
Participation of Opioid Receptors in the Cytoprotective Effect ofChronic Normobaric Hypoxia; Physiological Research; Vol. 68, iss. 2
Published: (2019)
Published: (2019)
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4
Published: (2024)
Published: (2024)
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression; Frontiers in Pharmacology; Vol. 10
Published: (2019)
Published: (2019)
Channeling and PXR experiments at the SAGA light source; RReps'11. Radiation from Relativistic Electrons in Periodic Structures
Published: (2011)
Published: (2011)
The Role of Cardiac Opioid Receptors in the Cardioprotective Effect of Continuous Normobaric Hypoxia; Bulletin of Experimental Biology and Medicine; Vol. 168, iss. 6
Published: (2020)
Published: (2020)
A novel urea derivative anticonvulsant: In vivo biological evaluation, radioreceptor analysis of GABAA receptors and molecular docking studies of enantiomers; Mendeleev Communications; Vol. 33, iss. 4
Published: (2023)
Published: (2023)
The position of 99mTc-HYNIC and the molecular design of the DARPin G3 constructs influence the selection of an imaging tracer to detect expression in HER2-expressing tumors; Journal of Radioanalytical and Nuclear Chemistry; Vol. 335
Published: (2026)
Published: (2026)
Влияние расположения ABD на таргетные свойства нового бивалентного терапевтического конъюгата на основе DARPin G3; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
by: Прач А. А. Анастасия Александровна
Published: (2024)
by: Прач А. А. Анастасия Александровна
Published: (2024)
Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape; Cancers; Vol. 12, iss. 10
Published: (2020)
Published: (2020)
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Published: (2018)
Published: (2018)
Continuous Normobaric Hypoxia Improved Cardiac Bioenergetics after Ischemia/Reperfusion: Role of Opioid Receptors; Bulletin of Experimental Biology and Medicine; Vol. 169, iss. 1
Published: (2020)
Published: (2020)
Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders; Neuropsychobiology; Vol. 75, iss. 4
Published: (2017)
Published: (2017)
Similar Items
-
Affibody Molecules as Targeting Vectors for PET Imaging; Cancers; Vol. 12, iss. 3
by: Tolmachev V. M. Vladimir Maksimilianovich
Published: (2020) -
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model; Cancers; Vol. 13, iss. 1
Published: (2020) -
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - iss. 9
Published: (2023) -
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer; Theranostics; Vol. 13, iss. 14
Published: (2023) -
Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules; International Journal of Molecular Sciences; Vol. 21, iss. 6
Published: (2020)